XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Series F Preferred Stock
Series G Preferred Stock
Preferred Stock
Common Stock
Paid-In Capital
Retained Earnings
Retained Earnings
Series F Preferred Stock
Retained Earnings
Series G Preferred Stock
Treasury Stock, at cost
Accumulated Other Comprehensive Income (Loss), Net of Tax
Beginning Balance at Dec. 31, 2020 $ 3,234,625     $ 145,037 $ 937 $ 1,109,532 $ 2,077,522     $ (140,659) $ 42,256
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 297,826           297,826        
Other comprehensive (loss), net of tax (40,748)                   (40,748)
Common stock dividends and equivalents (108,882)           (108,882)        
Preferred stock dividends   $ (5,906)           $ (5,906)      
Stock-based compensation 10,076         508       9,568  
Exercise of stock options 3,469         (5,155)       8,624  
Common shares acquired from stock compensation plan activity (4,271)                 (4,271)  
Ending Balance at Sep. 30, 2021 3,386,189     145,037 937 1,104,885 2,260,560     (126,738) 1,508
Beginning Balance at Jun. 30, 2021 3,329,705     145,037 937 1,101,126 2,203,160     (126,445) 5,890
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 95,713           95,713        
Other comprehensive (loss), net of tax (4,382)                   (4,382)
Common stock dividends and equivalents (36,345)           (36,345)        
Preferred stock dividends   (1,968)           (1,968)      
Stock-based compensation 3,643         3,819 0     (176)  
Exercise of stock options 83         (60)       143  
Common shares acquired from stock compensation plan activity (260)                 (260)  
Ending Balance at Sep. 30, 2021 3,386,189     145,037 937 1,104,885 2,260,560     (126,738) 1,508
Beginning Balance at Dec. 31, 2021 3,438,325     145,037 937 1,108,594 2,333,288     (126,951) (22,580)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 399,532           399,532        
Other comprehensive (loss), net of tax (714,321)                   (714,321)
Common stock dividends and equivalents (178,049)           (178,049)        
Preferred stock dividends   (5,906) $ (5,850)         (5,906) $ (5,850)    
Common stock contribution to charitable foundation 10,500         (1,701)       12,201  
Issued in business combination 5,180,124     138,942 891 5,040,291          
Stock-based compensation 43,231         14,726       28,505  
Exercise of stock options 635         (613)       1,248  
Common shares acquired from stock compensation plan activity (22,545)                 (22,545)  
Common stock repurchase program (319,266)                 (319,266)  
Ending Balance at Sep. 30, 2022 7,826,410     283,979 1,828 6,161,297 2,543,015     (426,808) (736,901)
Beginning Balance at Jun. 30, 2022 7,997,788     283,979 1,828 6,148,853 2,383,638     (339,178) (481,332)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 233,968           233,968        
Other comprehensive (loss), net of tax (255,569)                   (255,569)
Common stock dividends and equivalents (70,429)           (70,429)        
Preferred stock dividends   $ (1,968) $ (2,194)         $ (1,968) $ (2,194)    
Common stock contribution to charitable foundation 10,500         (1,701)       12,201  
Stock-based compensation 12,762         14,307       (1,545)  
Exercise of stock options 138         (162)       300  
Common shares acquired from stock compensation plan activity (1,450)                 (1,450)  
Common stock repurchase program (97,136)                 (97,136)  
Ending Balance at Sep. 30, 2022 $ 7,826,410     $ 283,979 $ 1,828 $ 6,161,297 $ 2,543,015     $ (426,808) $ (736,901)